76
|
Berg KA, Maayani S, McKay R, Clarke WP. Nerve growth factor amplifies cyclic AMP production in the HT4 neuronal cell line. J Neurochem 1995; 64:220-8. [PMID: 7798916 DOI: 10.1046/j.1471-4159.1995.64010220.x] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Abstract
There has been considerable interest and controversy in the relationship between nerve growth factor (NGF) and the cyclic AMP (cAMP) second messenger system. We have used a novel, neuronal cell line (HT4) to investigate the effect of NGF on the adenylyl cyclase signaling system. Treatment of cells with NGF (100 ng/ml, 15 min) amplified cAMP accumulation (approximately 75%) in response to activation of adenosine A2 receptors (5 min) with 5'-N-ethylcarboxamidoadenosine or activation of adenylyl cyclase directly with forskolin. Basal cAMP accumulation was not altered by NGF. This amplification appears to be mediated by activation of protein kinase C (PKC) because (1) it was mimicked by activators (phorbol esters and a diacylglycerol analogue) of PKC, (2) the effects of NGF and phorbol ester on cAMP accumulation were not additive, (3) NGF amplification of cAMP accumulation was abolished by down-regulation of PKC, (4) NGF increased cytosolic PKC activity, and (5) inhibitors of PKC blocked the NGF-induced amplification of cAMP accumulation. Although NGF-induced amplification of cAMP accumulation was dependent upon PKC, mechanisms other than the classic activation pathway (i.e., hydrolysis of inositol phospholipids or the production of diacylglycerol) appeared to mediate PKC activation by NGF. The tyrosine kinase inhibitor, lavendustin A, blocked NGF-mediated amplification of cAMP accumulation, suggesting a novel interaction between a tyrosine kinase and protein kinase C.
Collapse
|
77
|
Cunningham M, McKay R. Transplantation strategies for the analysis of brain development and repair. J Neurol 1994; 242:S40-2. [PMID: 7699408 DOI: 10.1007/bf00939241] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
Fetal tissue provides the best functional restoration in transplantation therapies for neurodegenerative diseases. Lineage analysis using in vivo cell marking methods shows that a multipotential cell gives rise to different neuronal types in the mammalian central nervous system. Culture methods that allow this cell to be expanded in vitro would provide important additional tools in the development of brain transplant therapies. The stem cells of the mammalian central nervous system express nestin, an intermediate filament protein that is abundant in neuronal and glial precursors but not present in the normal adult brain. Primary and immortal cultures of nestin-positive cells have been established and the differentiation of these cells analyzed both in vitro and by transplantation into the developing central nervous system. We have expanded neuronal precursor cells in vitro as both primary and immortal cells. Following implantation into the hippocampus, neurons derived from cultured stem cells are integrated into the host tissue. These findings encourage re-examination of the use of cultured cells in therapeutic transplants to the adult brain. In addition to increasing cell number, the period of culture may also permit genetic manipulation to define mechanisms of neuronal function and to enhance the therapeutic utility of transplanted cells.
Collapse
|
78
|
Dean NM, McKay R. Inhibition of protein kinase C-alpha expression in mice after systemic administration of phosphorothioate antisense oligodeoxynucleotides. Proc Natl Acad Sci U S A 1994; 91:11762-6. [PMID: 7972137 PMCID: PMC45312 DOI: 10.1073/pnas.91.24.11762] [Citation(s) in RCA: 188] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023] Open
Abstract
A 20-mer phosphorothioate oligodeoxynucleotide designed to hybridize to the AUG translation initiation codon of mRNA encoding murine protein kinase C-alpha (PKC-alpha) inhibits the expression of PKC-alpha both in vitro and in vivo. In mouse C127 mammary epithelial cells, the reduction in PKC-alpha mRNA expression was both dose and time dependent. The oligodeoxynucleotide exhibited an IC50 value of 100-200 nM and reduced PKC-alpha mRNA expression for up to 48 hr. This reduction was specific for PKC-alpha versus other PKC isozymes (delta, epsilon, and zeta) and completely dependent upon oligodeoxynucleotide sequence. When administered intraperitoneally in mice, the same oligodeoxynucleotide caused a dose-dependent, oligodeoxynucleotide sequence-dependent reduction of PKC-alpha mRNA in liver, with an IC50 value of 30-50 mg/kg of body weight. Inhibition of expression was 64 +/- 11% after a single 50-mg/kg dose. The expression of PKC-delta, epsilon, and zeta mRNA was unaffected by this treatment. The oligodeoxynucleotide activity in vivo did not require the presence of cationic liposomes or any other delivery systems, although in vitro, the oligodeoxynucleotide required cationic liposomes for inhibition of PKC-alpha expression. This study demonstrates the utility of phosphorothioate oligodeoxynucleotides as specific inhibitors of gene expression in vivo after systemic administration.
Collapse
|
79
|
Abreu P, Adam W, Adye T, Agasi E, Aleksan R, Alekseev GD, Algeri A, Almehed S, Alvsvaag SJ, Amaldi U, Andreazza A, Antilogus P, Apel WD, Apsimon RJ, Arnoud Y, �sman B, Augustin JE, Augustinus A, Baillon P, Bambade P, Barao F, Barate R, Barbiellini G, Bardin DY, Barker GJ, Baroncelli A, Barring O, Barrio JA, Bates MJ, Battaglia M, Baubillier M, Becks KH, Begalli M, Beilliere P, Belokopytov Y, Beltran P, Benedic D, Benvenuti AC, Berggren M, Bertrand D, Bianchi F, Bigi M, Bilenky MS, Billoir P, Bjarne J, Bloch D, Blocki J, Blyth S, Bocci V, Bogolubov PN, Bolognese T, Bonesini M, Bonivento W, Booth PSL, Borisov G, Borner H, Bosio C, Bostjancic B, Bosworth S, Botner O, Bouquet B, Bourdarios C, Bowcock TJV, Bozzo M, Braibant S, Branchini P, Brand KD, Brenner RA, Briand H, Bricman C, Brillaut L, Brown RCA, Brunet JM, Budziak A, Bugge L, Buran T, Burmeister H, Buys A, Buytaert JAMA, Caccia M, Calvi M, Rozas AJC, Campion R, Camporesi T, Canale V, Cankocak K, Cao F, Carena F, Carroll L, Caso C, Gimenez MVC, Cattai A, Cavallo FR, Cerrito L, Chabaud V, Chan A, Chapkin M, Charpentier P, Chaussard L, Chauveau J, Checchia P, Chelkov GA, Chevalier L, Chliapnikov P, Chorowicz V, Chrin JTM, Cindro V, Collins P, Contreras JL, Contri R, Cortina E, Cosme G, Couchot F, Crawley HB, Crennell D, Crosetti G, Maestro JC, Czellar S, Dahl-Jensen E, Dahm J, Dalmagne B, Dam M, Damgaard G, Daubie E, Daum A, Dauncey PD, Davenport M, Davies J, Silva W, Defoix C, Delpierre P, Demaria N, Angelis A, Boeck H, Boer W, Brabandere S, Clerq C, Fez Laso MDM, Vaissiere C, Lotto B, Min A, Dijkstra H, Ciaccio L, Dolbeau J, Donszelmann M, Doroba K, Dracos M, Drees J, Dris M, Dufour Y, Dupont F, Edsall D, Eek LO, Eerola PAM, Ehret R, Ekelof T, Ekspong G, Peisert AE, Elsing M, Engel JP, Ershaidat N, Santo ME, Fassouliotis D, Feindt M, Ferrer A, Filippas TA, Firestone A, Foeth H, Fokitis E, Fontanelli F, Forbes KAJ, Fousset JL, Francon S, Franek B, Frenkiel P, Fries DC, Frodesen AG, Fruhwirth R, Fulda-Quenzer F, Furstenau H, Fuster J, Gamba D, Garcia C, Garcia J, Gaspar C, Gasparini U, Gavillet P, Gazis EN, Gerber JP, Giacomelli P, Gillespie D, Gokieli R, Golob B, Golovatyuk VM, Gomez Y Cadenas JJ, Gopal G, Gorn L, Gorski M, Gracco V, Grant A, Grard F, Graziani E, Grosdidier G, Gross E, Grossetete B, Gunnarsson P, Guy J, Haedinger U, Hahn F, Hahn M, Hahn S, Haider S, Hajduk Z, Hakansson A, Hallgren A, Hamacher K, Hamel De Monchenault G, Hao W, Harris FJ, Hedberg V, Henkes T, Henriques R, Hernandez JJ, Hernando JA, Herquet P, Herr H, Hessing TL, Hietanen I, Higgins CO, Higon E, Hilke HJ, Hill TS, Hodgson SD, Hofmokl T, Holmgren SO, Holt PJ, Holthuizen D, Honore PF, Houlden M, Hrubec J, Huet K, Hultqvist K, Ioannou P, Iversen PS, Jackson JN, Jacobsson R, Jalocha P, Jarlskog G, Jarry P, Jean-Marie B, Johansson EK, Jonker M, Jonsson L, Juillot P, Kalkanis G, Kalmus G, Kapusta F, Karlsson M, Karvelas E, Katsanevas S, Katsoufis EC, Keranen R, Khomenko BA, Khovanski NN, King B, Kjaer NJ, Klein H, Klovning A, Kluit P, Koch-Mehrin A, Koehne JH, Koene B, Kokkinias P, Koratzinos M, Korcyl K, Korytov AV, Kostioukhine V, Kourkoumelis C, Kouznetsov O, Kramer PH, Krammer M, Kreuter C, Krolikowski J, Kronkvist I, Kucewicz W, Kulka K, Kurvinen K, Lacasta C, Lambropoulos C, Lamsa JW, Lanceri L, Langefeld P, Lapin V, Last I, Laugier JP, Lauhakangas R, Leder G, Ledroit F, Leitner R, Lemoigne Y, Lemonne J, Lenzen G, Lepeltier V, Lesiak T, Levy JM, Lieb E, Liko D, Lindgren J, Lindner R, Lippi I, Loerstad B, Lokajicek M, Loken JG, Lopez-Fernandez A, Lopez Aguera MA, Los M, Loukas D, Lozano JJ, Lutz P, Lyons L, Maehlum G, Maillard J, Maio A, Maltezos A, Mandl F, Marco J, Margoni M, Marin JC, Markou A, Maron T, Marti S, Martinez-Rivero C, Martinez-Vidal F, Matorras F, Matteuzzi C, Matthiae G, Mazzucato M, Mc Cubbin M, McKay R, McNulty R, Medbo J, Meroni C, Meyer WT, Michelotto M, Mikulec I, Mirabito L, Mitaroff WA, Mitselmakher GV, Mjoernmark U, Moa T, Moeller R, Moenig K, Monge MR, Morettini P, Mueller H, Murray WJ, Myatt G, Navarria FL, Negri P, Nemecek S, Neumann W, Nicolaidou R, Nielsen BS, Nijjhar B, Nikolaenko V, Nilsen PES, Niss P, Nomerotski A, Obraztsov V, Olshevski AG, Orava R, Ostankov A, Osterberg K, Ouraou A, Paganoni M, Pain R, Palka H, Papadopoulou TD, Pape L, Parodi F, Passeri A, Pegoraro M, Pennanen J, Peralta L, Perevozchikov V, Pernegger H, Pernicka M, Perrotta A, Petridou C, Petrolini A, Piana G, Pierre F, Pimenta M, Plaszczynski S, Podobrin O, Pol ME, Polok G, Poropat P, Pozdniakov V, Privitera P, Pullia A, Radojicic D, Ragazzi S, Rahmani H, Rames J, Ratoff PN, Read AL, Reale M, Rebecchi P, Redaelli NG, Regler M, Reid D, Renton PB, Resvanis LK, Richard F, Richardson J, Ridky J, Rinaudo G, Roditi I, Romero A, Roncagliolo I, Ronchese P, Ronnqvist C, Rosenberg EI, Rosso E, Rovelli T, Ruckstuhl W, Ruhlmann-Kleider V, Ruiz A, Saarikko H, Sacquin Y, Sajot G, Salt J, Sanchez J, Sannino M, Schael S, Schneider H, Schyns MAE, Sciolla G, Scuri F, Segar AM, Seitz A, Sekulin R, Sessa M, Seufert R, Shellard RC, Siccama I, Siegrist P, Simonetti S, Simonetto F, Sisakian AN, Skjevling G, Smadja G, Smirnov N, Smirnova O, Smith GR, Sosnowski R, Souza-Santos D, Spassoff T, Spiriti E, Squarcia S, Staeck H, Stanescu C, Stapnes S, Stavropoulos G, Stichelbaut F, Stocchi A, Strauss J, Straver J, Strub R, Stugu B, Szczekowski M, Szeptycka M, Szymanski P, Tabarelli T, Tchikilev O, Theodosiou GE, Tilquin A, Timmermans J, Timofeev VG, Tkatchev LG, Todorov T, Toet DZ, Toker O, Tomaradze A, Tome B, Torassa E, Tortora L, Treille D, Trischuk W, Tristram G, Troncon C, Tsirou A, Tsyganov EN, Turluer ML, Tuuva T, Tyapkin IA, Tyndel M, Tzamarias S, Ueberschaer B, Ueberschaer S, Ullaland O, Uvarov V, Valenti G, Vallazza E, Valls Ferrer JA, Velde C, Apeldoorn GW, Dam P, Heijden M, Doninck WK, Eldik J, Vaz P, Vegni G, Ventura L, Venus W, Verbeure F, Verlato M, Vertogradov LS, Vilanova D, Vincent P, Vitale L, Vlasov E, Vodopyanov AS, Vollmer M, Voutilainen M, Vrba V, Wahlen H, Walck C, Waldner F, Wehr A, Weierstall M, Weilhammer P, Wetherell AM, Wickens JH, Wielers M, Wilkinson GR, Williams WSC, Winter M, Witek M, Wormser G, Woschnagg K, Zaitsev A, Zalewska A, Zalewski P, Zavrtanik D, Zevgolatakos E, Zimin NI, Zito M, Zontar D, Zuberi R, Zumerle G, Zuniga J. Production rate and decay lifetime measurements ofB s 0 mesons at LEP usingD s and? mesons. ACTA ACUST UNITED AC 1994. [DOI: 10.1007/bf01413179] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
80
|
Dean NM, McKay R, Condon TP, Bennett CF. Inhibition of protein kinase C-alpha expression in human A549 cells by antisense oligonucleotides inhibits induction of intercellular adhesion molecule 1 (ICAM-1) mRNA by phorbol esters. J Biol Chem 1994; 269:16416-24. [PMID: 7911467] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023] Open
Abstract
We have identified 20-mer phosphorothioate oligodeoxynucleotides which potently (IC50 values of 100-200 nM) and specifically inhibit protein kinase C (PKC)-alpha mRNA and protein expression in human lung carcinoma (A549) cells. These oligonucleotides target multiple, diverse sites on PKC-alpha mRNA including the AUG translation codon and 3'-untranslated sequences. 2'-O-Methyl phosphorothioate analogs of these oligonucleotides were without effect on PKC-alpha mRNA levels, suggesting that the reduction in targeted PKC-alpha mRNA is through RNase H-mediated cleavage. One oligonucleotide, however, was effective at inhibiting PKC-alpha protein levels as a 2'-O-methyl phosphorothioate at concentrations 2-3-fold greater than its phosphorothioate/deoxy homolog. These results suggest that the ability to serve as an RNase H substrate, although not required for all oligonucleotides, certainly increases their potency. These oligonucleotides have been used to examine the role played by PKC-alpha in mediating the phorbol ester-induced changes in mRNA levels of the cell adhesion molecule ICAM-1. In A549 cells, ICAM-1 mRNA is increased 10-20-fold by treatment of cells with the phorbol ester phorbol 12-myristate 13-acetate. When PKC-alpha protein levels are depleted by oligonucleotide treatment of A549 cells, the increase in ICAM-1 expression in response to phorbol 12-myristate 13-acetate is greatly reduced, demonstrating that PKC-alpha plays a major role in this process.
Collapse
|
81
|
Dean N, McKay R, Condon T, Bennett C. Inhibition of protein kinase C-alpha expression in human A549 cells by antisense oligonucleotides inhibits induction of intercellular adhesion molecule 1 (ICAM-1) mRNA by phorbol esters. J Biol Chem 1994. [DOI: 10.1016/s0021-9258(17)34023-1] [Citation(s) in RCA: 212] [Impact Index Per Article: 7.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
82
|
Zimmerman L, Parr B, Lendahl U, Cunningham M, McKay R, Gavin B, Mann J, Vassileva G, McMahon A. Independent regulatory elements in the nestin gene direct transgene expression to neural stem cells or muscle precursors. Neuron 1994; 12:11-24. [PMID: 8292356 DOI: 10.1016/0896-6273(94)90148-1] [Citation(s) in RCA: 467] [Impact Index Per Article: 15.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
Abstract
Changes in intermediate filament gene expression occur at key steps in the differentiation of cell types in the mammalian CNS. Neuroepithelial stem cells express the intermediate filament protein nestin and down-regulate it sharply at the transition from proliferating stem cell to postmitotic neuron. Nestin is also expressed in muscle precursors but not in mature muscle cells. We show here that in transgenic mice, independent cell type-specific elements in the first and second introns of the nestin gene consistently direct reporter gene expression to developing muscle and neural precursors, respectively. The second intron contains an enhancer that functions in CNS stem cells, suggesting that there may be a single transcriptional mechanism regulating the CNS stem cell state. This enhancer is much less active in the PNS. The identification of these elements facilitates analysis of mechanisms controlling the switch in gene expression that occurs when muscle and brain precursors terminally differentiate.
Collapse
|
83
|
McKay R, Renfranz P, Cunningham M. Immortalized stem cells from the central nervous system. COMPTES RENDUS DE L'ACADEMIE DES SCIENCES. SERIE III, SCIENCES DE LA VIE 1993; 316:1452-1457. [PMID: 8087624] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
Abstract
A remarkable feature of the early development of the mammalian central nervous system (CNS) is the precise and rapid generation of large numbers of many different neuronal types [1]. We have identified the major neuronal precursor cell and shown that this cell can be immortalized by oncogenes. The immortal precursor cell can be grown in culture and can differentiate when transplanted into the developing brain. The implanted neurons are integrated into the synaptic circuitry of the host brain. These results suggest that implanting cultured precursor cells will provide a powerful strategy to uncover the signals that control the differentiation of this multipotential cell into the many cell types of the adult brain.
Collapse
|
84
|
Kantoch MJ, McKay R, Tyrrell MJ. Left ventricular transvenous electrode dislodgement after Mustard repair for transposition of the great arteries. Pacing Clin Electrophysiol 1993; 16:1887-91. [PMID: 7692423 DOI: 10.1111/j.1540-8159.1993.tb01825.x] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
An 11-year-old girl who underwent Mustard's operation for complete transposition of the great arteries in infancy, developed Mobitz type II second-degree AV block 8 1/2 years later. A transvenous, active fixation left ventricular lead was inserted and connected to a rate responsive pacemaker. Two years later the lead dislodged due to the child's growth. A new active fixation electrode was positioned in the left ventricle below the pulmonary valve, leaving an electrode loop in the ventricle. Such an approach may prevent lead dislodgement due to growth after intraatrial repair for transposition of the great arteries, but regular radiological or echocardiographic follow-up of lead position is recommended in these patients.
Collapse
|
85
|
Weber A, Willeke K, Marchioni R, Myojo T, McKay R, Donnelly J, Liebhaber F. Aerosol penetration and leakage characteristics of masks used in the health care industry. Am J Infect Control 1993; 21:167-73. [PMID: 8239046 DOI: 10.1016/0196-6553(93)90027-2] [Citation(s) in RCA: 116] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
Abstract
BACKGROUND Historically, surgical masks have been worn to protect patients from being infected by large, pathogen-containing aerosol droplets emitted by health care personnel. Today, emphasis has shifted from solely protecting the patient to protecting the health care worker as well. As a result of new procedures used in operating rooms and clinical areas, aerosolized hazardous agents in the submicrometer size range are being produced, posing a potential threat to health care workers. METHODS Eight surgical masks were tested for aerosol particle penetration through their filter media and through induced face-seal leaks. RESULTS The percentage of filter penetration ranged from 20% to nearly 100% for submicrometer-sized particles. In comparison, a dust-mist-fume respirator used in industrial settings had significantly less penetration through its filter medium. When the surgical masks had artificially induced face-seal leaks, the concentration of submicrometer-sized particles inside the mask increased slightly; in contrast, the more protective dust-mist-fume respirator showed a fourfold increase in aerosol penetration into the mask with an artificial leak 4 mm in diameter. CONCLUSION We conclude that the protection provided by surgical masks may be insufficient in environments containing potentially hazardous submicrometer-sized aerosols.
Collapse
|
86
|
Abreu P, Adam W, Adye T, Agasi E, Alekseev GD, Algeri A, Allen P, Almehed S, Alvsvaag SJ, Amaldi U, Anassontzis EG, Andreazza A, Antilogus P, Apel WD, Apsimon RJ, Åsman B, Augustin JE, Augustinus A, Baillon P, Bambade P, Barao F, Barate R, Barbiellini G, Bardin DY, Barker GJ, Baroncelli A, Barring O, Barrio JA, Bartl W, Bates MJ, Battaglia M, Baubillier M, Becks KH, Beeston CJ, Begalli M, Beilliere P, Belokopytov Y, Beltran P, Benedic D, Benvenuti AC, Berggren M, Bertrand D, Bianchi F, Bilenky MS, Billoir P, Bjarne J, Bloch D, Blyth S, Bocci V, Bogolubov PN, Bolognese T, Bonesini M, Bonivento W, Booth PSL, Borgeaud P, Borisov G, Borner H, Bosio C, Bostjancic B, Bosworth S, Botner O, Bouquet B, Bourdarios C, Bowcock TJV, Bozzo M, Braibant S, Branchini P, Brand KD, Brenner RA, Briand H, Bricman C, Brown RCA, Brummer N, Brunet JM, Bugge L, Buran T, Burmeister H, Buytaert JAMA, Caccia M, Calvi M, Camacho Rozas AJ, Campion R, Camporesi T, Canale V, Cao F, Carena F, Carroll L, Caso C, Castillo Gimenez MV, Cattai A, Cavallo FR, Cerrito L, Chabaud V, Chan A, Charpentier P, Chaussard L, Chauveau J, Checchia P, Chelkov GA, Chevalier L, Chliapnikov P, Chorowicz V, Chrin JTM, Clara MP, Collins P, Contreras JL, Contri R, Cortina E, Cosme G, Couchot F, Crawley HB, Crennell D, Crosetti G, Crozon M, Maestro JC, Czellar S, Dahl-Jensen E, Dalmagne B, Dam M, Damgaard G, Darbo G, Daubie E, Daum A, Dauncey PD, Davenport M, David P, Davies J, Silva W, Defoix C, Delikaris D, Delorme S, Delpierre P, Demaria N, Angelis A, Beer M, Boeck H, Boer W, Clercq C, Fez Laso MDM, Groot N, Vaissiere C, Lotto B, Min A, Dijkstra H, Ciaccio L, Djama F, Dolbeau J, Donszelmann M, Doroba K, Dracos M, Drees J, Dris M, Dufour Y, Eek LO, Eerola PAM, Ehret R, Ekelof T, Ekspong G, Elliot Peisert A, Engel JP, Ershaidat N, Fassouliotis D, Feindt M, Fernandez Alonso M, Ferrer A, Filippas TA, Firestone A, Foeth H, Fokitis E, Fontanelli F, Forbes KAJ, Fousset JL, Francon S, Franek B, Frenkiel P, Fries DC, Frodesen AG, Fruhwirth R, Fulda-Quenzer F, Furnival K, Furstenau H, Fuster J, Galeazzi G, Gamba D, Garcia C, Garcia J, Gaspar C, Gasparini U, Gavillet P, Gazis EN, Gerber JP, Giacomelli P, Gokieli R, Golob B, Golovatyuk VM, Gomez Y Cadenas JJ, Goobar A, Gopal G, Gorski M, Gracco V, Grant A, Grard F, Graziani E, Grosdidier G, Gross E, Grosse-Wiesmann P, Grossetete B, Gumenyuk S, Guy J, Haedinger U, Hahn F, Hahn M, Haider S, Hakansson A, Hallgren A, Hamacher K, Hamel De Monchenault G, Hao W, Harris FJ, Henkes T, Hernandez JJ, Herquet P, Herr H, Hessing TL, Hietanen I, Higgins CO, Higon E, Hilke HJ, Hodgson SD, Hofmokl T, Holmes R, Holmgren SO, Holthuizen D, Honore PF, Hooper JE, Houlden M, Hrubec J, Huet K, Hulth PO, Hultqvist K, Ioannou P, Isenhower D, Iversen PS, Jackson JN, Jalocha P, Jarlskog G, Jarry P, Jean-Marie B, Johansson EK, Johnson D, Jonker M, Jonsson L, Juillot P, Kalkanis G, Kalmus G, Kapusta F, Karlsson M, Karvelas E, Katsanevas S, Katsoufis EC, Keranen R, Kesteman J, Khomenko BA, Khovanski NN, King B, Kjaer NJ, Klein H, Klempt W, Klovning A, Kluit P, Koch-Mehrin A, Koehne JH, Koene B, Kokkinias P, Kopf M, Korcyl K, Korytov AV, Kostioukhine V, Kourkoumelis C, Kouznetsov O, Kramer PH, Krolikowski J, Kronkvist I, Kruener-Marquis U, Krupinski W, Kulka K, Kurvinen K, Lacasta C, Lambropoulos C, Lamsa JW, Lanceri L, Lapin V, Laugier JP, Lauhakangas R, Leder G, Ledroit F, Leitner R, Lemoigne Y, Lemonne J, Lenzen G, Lepeltier V, Lesiak T, Levy JM, Lieb E, Liko D, Lindgren J, Lindner R, Lipniacka A, Lippi I, Loerstad B, Lokajicek M, Loken JG, Lopez-Fernandez A, Lopez Aguera MA, Los M, Loukas D, Lozano JJ, Lutz P, Lyons L, Maehlum G, Maillard J, Maltezos A, Mandl F, Marco J, Margoni M, Marin JC, Markou A, Maron T, Marti S, Mathis L, Matorras F, Matteuzzi C, Matthiae G, Mazzucato M, McCubbin M, McKay R, McNulty R, Meola G, Meroni C, Meyer WT, Michelotto M, Mikulec I, Mirabito L, Mitaroff WA, Mitselmakher GV, Mjoernmark U, Moa T, Moeller R, Moenig K, Monge MR, Morettini P, Mueller H, Murray WJ, Muryn B, Myatt G, Navarria FL, Negri P, Nielsen BS, Nijjhar B, Nikolaenko V, Nilsen PES, Niss P, Obraztsov V, Olshevski AG, Orava R, Ostankov A, Osterberg K, Ouraou A, Paganoni M, Pain R, Palka H, Papadopoulou TD, Pape L, Passeri A, Pegoraro M, Pennanen J, Perevozchikov V, Pernicka M, Perrotta A, Petridou C, Petrolini A, Petrovykh L, Pettersen TE, Pierre F, Pimenta M, Pingot O, Plaszczynski S, Pol ME, Polok G, Poropat P, Privitera P, Pullia A, Radojicic D, Ragazzi S, Rahmani H, Ratoff PN, Read AL, Redaelli NG, Regler M, Reid D, Renton PB, Resvanis LK, Richard F, Richardson M, Ridky J, Rinaudo G, Roditi I, Romero A, Roncagliolo I, Ronchese P, Ronnqvist C, Rosenberg EI, Rossi S, Rossi U, Rosso E, Roudeau P, Rovelli T, Ruckstuhl W, Ruhlmann-Kleider V, Ruiz A, Rybicki K, Saarikko H, Sacquin Y, Sajot G, Salt J, Sanchez J, Sannino M, Schael S, Schneider H, Schulze B, Schyns MAE, Sciolla G, Scuri F, Segar AM, Sekulin R, Sessa M, Sette G, Seufert R, Shellard RC, Siccama I, Siegrist P, Simonetti S, Simonetto F, Sisakian AN, Skaali TB, Skjevling G, Smadja G, Smith GR, Sosnowski R, Spassoff TS, Spiriti E, Squarcia S, Staeck H, Stanescu C, Stapnes S, Stavropoulos G, Stichelbaut F, Stocchi A, Strauss J, Straver J, Strub R, Szczekowski M, Szeptycka M, Szymanski P, Tabarelli T, Tavernier S, Tchikilev O, Theodosiou GE, Tilquin A, Timmermans J, Timofeev VG, Tkatchev LG, Todorov T, Toet DZ, Toker O, Torassa E, Tortora L, Treille D, Trevisan U, Trischuk W, Tristram G, Troncon C, Tsirou A, Tsyganov EN, Turala M, Turluer ML, Tuuva T, Tyapkin IA, Tyndel M, Tzamarias S, Ueberschaer S, Ullaland O, Uvarov V, Valenti G, Vallazza E, Valls Ferrer JA, Velde C, Apeldoorn GW, Dam P, Heijden M, Doninck WK, Vaz P, Vegni G, Ventura L, Venus W, Verbeure F, Vertogradov LS, Vilanova D, Vincent P, Vitale L, Vlasov E, Vodopyanov AS, Vollmer M, Voulgaris G, Voutilainen M, Vrba V, Wahlen H, Walck C, Waldner F, Wayne M, Wehr A, Weierstall M, Weilhammer P, Werner J, Wetherell AM, Wickens JH, Wikne J, Wilkinson GR, Williams WSC, Winter M, Witek M, Wormald D, Wormser G, Woschnagg K, Yamdagni N, Yepes P, Zaitsev A, Zalewska A, Zalewski P, Zavrtanik D, Zevgolatakos E, Zhang G, Zimin NI, Zito M, Zuberi R, Zukanovich Funchal R, Zumerle G, Zuniga J. A measurement ofB meson production and lifetime usingDl − events inZ 0 decays. ACTA ACUST UNITED AC 1993. [DOI: 10.1007/bf01565048] [Citation(s) in RCA: 23] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
87
|
Alvarado O, Sreeram N, McKay R, Boyd IM. Cavopulmonary connection in repair of atrioventricular septal defect with small right ventricle. Ann Thorac Surg 1993; 55:729-36. [PMID: 8452439 DOI: 10.1016/0003-4975(93)90284-o] [Citation(s) in RCA: 29] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
Abstract
Between February 1991 and May 1992, 9 patients with a nonrestrictive inlet ventricular septal defect or complete atrioventricular septal defect and hypoplasia of the right ventricle underwent successful two-ventricle correction incorporating a bidirectional cavopulmonary anastomosis. Despite a satisfactory early postoperative course, large serous pleural effusions developed in 5 of them between 2 and 6 weeks after operation. Serial echocardiography showed an evolution of flow patterns in the superior vena cava from marked systolic reversal immediately after operation to nearly continuous forward flow into both pulmonary arteries about 6 weeks later. This pattern was consistent with the transition from cardiac-dependent to respiratory-dependent caval flow. The development of pleural effusions appeared to coincide with the loss of systolic caval flow reversal and resolved after establishment of a predominantly respiratory-dependent flow pattern.
Collapse
|
88
|
McKay R. Invited letter concerning: critical aortic stenosis. J Thorac Cardiovasc Surg 1993; 105:365-7. [PMID: 8429666] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
|
89
|
Abstract
The aortic valve is a beautifully designed and balanced structure with precise opening and closing mechanisms. Its design probably cannot be improved upon by man-made mechanical devices, no matter how ingenious. It is logical to use human valves as replacements because of their superior structural configuration. Their chief difficulties are in the troubles of the learning curve of the surgeon to achieve a competent mechanism and the hazard of infection. The pulmonary autograft or translocation of the pulmonary valve to the aortic position offers many advantages, and the long-term results are good. Conservative repair and reconstruction of the aortic valve are increasing in popularity but have a relatively limited application. The mitral valve has a less precise and more adjustable type of mechanism and generous leaflet coaptation. These features make it more amenable to repair, as demonstrated in the clinical series of the technique. Repair is clearly preferable to replacement at present. The tricuspid valve is eminently suitable for reconstruction, but late results are not very good. The disappointing outcome, however, reflects more the severity of underlying cardiac pathology than the effectiveness of the repair.
Collapse
|
90
|
Ziskind AA, Pearce AC, Lemmon CC, Burstein S, Gimple LW, Herrmann HC, McKay R, Block PC, Waldman H, Palacios IF. Percutaneous balloon pericardiotomy for the treatment of cardiac tamponade and large pericardial effusions: description of technique and report of the first 50 cases. J Am Coll Cardiol 1993; 21:1-5. [PMID: 8417048 DOI: 10.1016/0735-1097(93)90710-i] [Citation(s) in RCA: 126] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
Abstract
OBJECTIVES This study describes the technique, clinical characteristics and results of the first 50 patients undergoing percutaneous balloon pericardiotomy as part of a multicenter registry. BACKGROUND Percutaneous balloon pericardiotomy involves the use of a percutaneous balloon dilating catheter to create a nonsurgical pericardial window. METHODS Patients eligible for percutaneous balloon pericardiotomy had either cardiac tamponade (n = 36) or a moderate to large pericardial effusion (n = 14). In addition to clinical follow-up, serial echocardiograms and chest X-ray films were obtained. RESULTS The procedure was considered successful in 46 patients after a mean follow-up period of 3.6 +/- 3.3 months. Two patients required an early operation, one for bleeding from a pericardial vessel and one for persistent pericardial catheter drainage. Two patients required a late operation for recurrent tamponade. Minor complications of the procedure included fever in 6 of the first 37 patients (studied before the prophylactic use of antibiotic agents), thoracentesis or chest tube placement in 8 and a small spontaneously resolving pneumothorax in 2. Despite the short-term success of this procedure, the long-term prognosis of the 44 patients with malignant pericardial disease remained poor (mean survival time 3.3 +/- 3.1 months). CONCLUSIONS Percutaneous balloon pericardiotomy is successful in helping to manage large pericardial effusions, particularly in patients with a malignant condition. It may become the preferred treatment to avoid a more invasive procedure for patients with pericardial effusion and a limited life expectancy.
Collapse
|
91
|
Abstract
The functional differences between the many mature neuronal types make the origins of cellular diversity in the nervous system one of the most intriguing problems in biology. This paper discusses recent experiments which explore the mechanisms generating cell diversity in the vertebrate central nervous system, focusing particularly on the immediate precursor to neurons and on neuronal differentiation. Transplantation experiments have been used to explore regional and temporal differences in the cells of the neuroepithelium. The effects of specific genes on neuronal development have been examined by mutational analysis in transgenic mice and in established neuronal stem cell lines. The combination of methods now available allow increasingly powerful dissection of the molecular and cellular mechanisms that generate the large number of different neurons in the vertebrate brain.
Collapse
|
92
|
Abstract
Several recent experiments have shown that immortal neural and muscle cells retain the specific temporal and spatial properties of their precursor cells in the animal. In addition, the immortal cells retain the ability to differentiate in vitro and, after transplantation, in vivo. The results of these experiments suggest that the use of precursor cell lines may lead to powerful approaches for understanding the mechanisms that generate the ordered distribution of cell types in mammals.
Collapse
|
93
|
McKay R, Smith A, Leung MP, Arnold R, Anderson RH. Morphology of the ventriculoaortic junction in critical aortic stenosis. Implications for hemodynamic function and clinical management. J Thorac Cardiovasc Surg 1992; 104:434-42. [PMID: 1495307] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
The clinical presentation of infants with critical aortic stenosis, as well as the results of surgical treatment, differs from obstruction of the left ventricular outflow tract in older children. To investigate a possible anatomic basis for this situation, we performed a detailed morphometric study of 21 hearts from infants who had critical aortic stenosis and 11 normal hearts from infants less than 3 months of age. In each of the hearts with critical aortic stenosis, only one commissure extended to the sinutubular ridge. The other two commissures were represented by folds in the aortic wall that suspended the leaflet below the level of the sinutubular junction. The leaflet thus had a free edge shorter than the circumference of the sinus, in contrast with the normal valve, in which leaflets always were longer than the circumference of their supporting sinus. Analysis of the fibrous triangles on the ventricular aspect of abnormal valves showed a symmetric three-sinus arrangement. In all but one specimen, however, only the triangle related to the mitral valve was fully developed. Although incision of both rudimentary commissures to the aortic wall should achieve some relief of obstruction, these morphologic features strongly mitigate against surgical restoration of normal function or growth in aortic valves having the morphology observed in this series of hearts.
Collapse
|
94
|
Asante-Korang A, Sreeram N, McKay R, Arnold R. Thrombolysis with tissue-type plasminogen activator following cardiac surgery in children. Int J Cardiol 1992; 35:317-22. [PMID: 1612794 DOI: 10.1016/0167-5273(92)90229-v] [Citation(s) in RCA: 34] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
Three children with major intracardiac or vascular thrombosis following cardiac operations were treated with intravenous recombinant tissue-type plasminogen activator. The first patient, aged 10 yr, developed a left atrial thrombus following replacement of the mitral valve with a Björk-Shiley prosthesis. The second patient, aged 16 months, had a right atrial thrombus following a modified Fontan procedure for tricuspid atresia. Both were successfully treated with a short course of intravenous tissue plasminogen activator. The third patient, aged 19 months, developed the Budd-Chiari syndrome with occlusion of the inferior caval vein following a modified Fontan operation for double inlet left ventricle. Even though near-complete thrombolysis and recanalization of the inferior caval vein was achieved with three courses of tissue plasminogen activator on successive days, she died with failure of multiple organs. In all cases, the diagnosis was established by cross-sectional and Doppler echocardiography, and the response to therapy was monitored using the same technique. Thrombolytic therapy with systemic tissue-type plasminogen activator was safe and effective in the postoperative period, with no major haemorrhagic complications.
Collapse
|
95
|
Abstract
We have established permanent cell lines from the optic nerve of the rat with a temperature sensitive immortalizing oncogene (Simian Virus 40 large T-antigen carrying both the tsA58 and U19 mutations). The oncogene was transduced into primary cultures via a replication deficient retrovirus, and infected cells were selected with the antibiotic G418. A clonal cell line (tsU19-5) displayed some properties of oligodendrocyte precursors: it proliferated, bound the monoclonal antibody A2B5 (which recognizes minor ganglioside species), and expressed the intermediate filament vimentin and the enzyme 2',3'-cyclic-nucleotide 3'-phosphodiesterase (CNP) at 33 degrees C (the permissive temperature for the oncogene). At 39 degrees C (the non-permissive temperature), some cells had the potential to differentiate further, and expressed several oligodendrocyte specific components: galactocerebroside, myelin basic protein, proteolipid protein and CNP. These results suggest that conditional oncogenes can establish neural precursor cell lines which are still capable of differentiation in vitro.
Collapse
|
96
|
Abstract
A three-year-old girl presented with a gunshot wound of the chest. Cross-sectional and Doppler echocardiography enabled precise location of the bullet, and assessment of the haemodynamic effects of the traumatic ventricular septal defect. Serial ultrasound examination in the acute stage confirmed that the bullet was well embedded in the left ventricular myocardium, and the ventricular septal defect was restrictive, enabling conservative management.
Collapse
|
97
|
Wenstone R, Campbell JM, Booker PD, McKay R. Renal function after cardiopulmonary bypass in children: comparison of dopamine with dobutamine. Br J Anaesth 1991; 67:591-4. [PMID: 1751274 DOI: 10.1093/bja/67.5.591] [Citation(s) in RCA: 28] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022] Open
Abstract
We have compared low dose dopamine with dobutamine in conserving renal function in 142 children younger than 10 yr undergoing cardiopulmonary bypass (CPB). Patients were allocated randomly to receive a continuous infusion of either dopamine 2.5 micrograms kg-1 min-1 (group 1) or dobutamine 2.5 micrograms kg-1 min-1 (group 2) from the time of induction of anaesthesia. Administration of inotropes and diuretics was controlled strictly to agreed regimens. There was no clinical or statistically significant difference between the two groups in postoperative urine output, serum concentration of creatinine, fractional sodium excretion or need for diuretic therapy. This was true also of the subgroup of patients who received no other inotropic support. However, the subgroup of patients in group 1 who underwent periods of CPB in excess of 2 h (n = 17) had persistently greater postoperative serum concentrations of creatinine. Low dose dopamine did not appear to be superior to dobutamine for protection of renal function in these patients.
Collapse
|
98
|
Anderson RH, Devine WA, Ho SY, Smith A, McKay R. The myth of the aortic annulus: the anatomy of the subaortic outflow tract. Ann Thorac Surg 1991; 52:640-6. [PMID: 1898167 DOI: 10.1016/0003-4975(91)90966-t] [Citation(s) in RCA: 88] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
Surgical repair of the small aortic root is limited in part by the very structure of the outflow tract from the left ventricle. The root is not constructed on the basis of a ringlike annulus supporting the leaflets of the aortic valve. The only truly circular structure within the outflow tract is the junction of the aortic wall with the underlying ventricular structures, themselves partly muscular and partly fibrous. This circular ventriculoarterial junction is crossed by the semilunar attachments of the leaflets of the aortic valve, producing an interlinking arrangement between the expanded aortic sinuses and three triangles of fibrous tissue placed beneath the apexes of the commissures between the valve leaflets. The triangles form extensions of the left ventricle that are related, in part, to the pericardial cavity surrounding the heart. The arrangements of the attachment of the leaflets in malformed valves with two (or only one) effective leaflets are highly abnormal, although these valves are usually produced on the template of three aortic sinuses. The valve with two leaflets rarely gives problems during childhood. In valves producing "critical stenosis", there is usually only one effective leaflet, a condition due to incomplete liberation of two of the anticipated three commissures. Detailed study shows that, in these malformed hearts, the attachment of the leaflets is much more annular than in normal valves, with inadequate formation of the fibrous triangles.
Collapse
|
99
|
Abstract
Fetal brain tissue has been shown to have clear behavioral effects when transplanted into adult lesioned brains. These results have focused attention on the cell types of the embryonic brain. Transplantation experiments using primary cells are beginning to define the plasticity of these cells and the times when they become committed to specific neuronal fates. Growth factors have been defined that regulate the proliferation of these cells in culture. Cell lines have been established that express stem cell properties and that are capable of differentiation when implanted into the developing brain. In this article we review this work on mammalian neuroepithelial stem cells and discuss how these studies might contribute to the therapeutic use of brain transplants.
Collapse
|
100
|
Sreeram N, Saleem M, Jackson M, Peart I, McKay R, Arnold R, Walsh K. Results of balloon pulmonary valvuloplasty as a palliative procedure in tetralogy of Fallot. J Am Coll Cardiol 1991; 18:159-65. [PMID: 1711062 DOI: 10.1016/s0735-1097(10)80235-9] [Citation(s) in RCA: 60] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
Balloon pulmonary valvuloplasty was attempted in 67 patients with tetralogy of Fallot at a median age of 5 months (range 0.03 to 52 months) for relief of cyanosis. In three patients, the valve could not be crossed and an aortopulmonary shunt was performed. In 35 patients, follow-up angiography was performed 3 to 30 months (average 12) after valvuloplasty. In 24 of these 35 patients (group A), the stenosis had been adequately palliated by valvuloplasty; the other 11 patients (group B) had required an aortopulmonary shunt 1 month (range 0 to 3 months) after valvuloplasty. The two groups were similar (p greater than 0.1) with respect to age at valvuloplasty, pulmonary anulus diameter, ratio of pulmonary artery to descending aorta diameter before valvuloplasty and interval to follow-up angiography. In contrast to patients in group B, patients in group A had a significant immediate improvement in systemic arterial oxygen saturation (p less than 0.01) and a significant increase in pulmonary anulus diameter at follow-up angiography (p less than 0.001). The growth of the branch pulmonary arteries was similar (p greater than 0.1) in the two groups. Among 42 patients who have had surgical correction, a transannular patch for right ventricular outflow tract reconstruction was used in 27 (64%); there was no difference between groups A and B with respect to its use. Eight patients died (three after repair) and death could not be directly attributed to valvuloplasty in any. Balloon valvuloplasty promotes growth of the pulmonary valve anulus and pulmonary arteries and is a useful alternative to an aortopulmonary shunt in patients with small pulmonary arteries or associated complex intracardiac defects.
Collapse
|